1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Veterinary Imaging Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Type Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
5. Key Insights
    5.1. Technological Advancements
    5.2. Veterinary Imaging & Prevalence Rate of Veterinary Conditions
    5.3. COVID-19 Pandemic Impact on Industry
6. Global Veterinary Imaging Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Equipment
            6.3.1.1. Radiography (X-ray)
            6.3.1.2. Ultrasound Imaging
            6.3.1.3. Magnetic Resonance Imaging (MRI)
            6.3.1.4. Computed Tomography
            6.3.1.5. Endoscopy
            6.3.1.6. Others
        6.3.2. Imaging Reagents
        6.3.3. Imaging Software
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Veterinary Imaging Market Analysis and Forecast, by Animal Type
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Animal Type, 2017–2031
        7.3.1. Small Animals
        7.3.2. Large Animals
    7.4. Market Attractiveness Analysis, by Animal Type
8. Global Veterinary Imaging Market Analysis and Forecast, by Application
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Application, 2017–2031
        8.3.1. Oncology
        8.3.2. Orthopedics
        8.3.3. Neurology
        8.3.4. Cardiology
        8.3.5. Others
    8.4. Market Attractiveness Analysis, by Application
9. Global Veterinary Imaging Market Analysis and Forecast, by End-user
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by End-user, 2017–2031
        9.3.1. Veterinary Clinics
        9.3.2. Veterinary Hospitals
        9.3.3. Veterinary Institutes & Research Centers
    9.4. Market Attractiveness Analysis, by End-user
10. Global Veterinary Imaging Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region, 2017–2031
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness By Country/Region
11. North America Veterinary Imaging Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017–2031
        11.2.1. Equipment
            11.2.1.1. Radiography (X-ray)
            11.2.1.2. Ultrasound Imaging
            11.2.1.3. Magnetic Resonance Imaging (MRI)
            11.2.1.4. Computed Tomography
            11.2.1.5. Endoscopy
            11.2.1.6. Others
        11.2.2. Imaging Reagents
        11.2.3. Imaging Software
    11.3. Market Value Forecast, by Animal Type, 2017–2031
        11.3.1. Small Animals
        11.3.2. Large Animals
    11.4. Market Value Forecast, by Application, 2017–2031
        11.4.1. Oncology
        11.4.2. Orthopedics
        11.4.3. Neurology
        11.4.4. Cardiology
        11.4.5. Others
    11.5. Market Value Forecast, by End-user, 2017–2031
        11.5.1. Veterinary Clinics
        11.5.2. Veterinary Hospitals
        11.5.3. Veterinary Institutes & Research Centers
    11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Product Type
        11.7.2. By Animal Type
        11.7.3. By Application
        11.7.4. By End-user
        11.7.5. By Country/Sub-region
12. Europe Veterinary Imaging Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017–2031
        12.2.1. Equipment
            12.2.1.1. Radiography (X-ray)
            12.2.1.2. Ultrasound Imaging
            12.2.1.3. Magnetic Resonance Imaging (MRI)
            12.2.1.4. Computed Tomography
            12.2.1.5. Endoscopy
            12.2.1.6. Others
        12.2.2. Imaging Reagents
        12.2.3. Imaging Software
    12.3. Market Value Forecast, by Animal Type, 2017–2031
        12.3.1. Small Animals
        12.3.2. Large Animals
    12.4. Market Value Forecast, by Application, 2017–2031
        12.4.1. Oncology
        12.4.2. Orthopedics
        12.4.3. Neurology
        12.4.4. Cardiology
        12.4.5. Others
    12.5. Market Value Forecast, by End-user, 2017–2031
        12.5.1. Veterinary Clinics
        12.5.2. Veterinary Hospitals
        12.5.3. Veterinary Institutes & Research Centers
    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.6.1. Germany
        12.6.2. UK
        12.6.3. France
        12.6.4. Italy
        12.6.5. Spain
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Product Type
        12.7.2. By Animal Type
        12.7.3. By Application
        12.7.4. By End-user
        12.7.5. By Country/Sub-region
13. Asia Pacific Veterinary Imaging Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017–2031
        13.2.1. Equipment
            13.2.1.1. Radiography (X-ray)
            13.2.1.2. Ultrasound Imaging
            13.2.1.3. Magnetic Resonance Imaging (MRI)
            13.2.1.4. Computed Tomography
            13.2.1.5. Endoscopy
            13.2.1.6. Others
        13.2.2. Imaging Reagents
        13.2.3. Imaging Software
    13.3. Market Value Forecast, by Animal Type, 2017–2031
        13.3.1. Small Animals
        13.3.2. Large Animals
    13.4. Market Value Forecast, by Application, 2017–2031
        13.4.1. Oncology
        13.4.2. Orthopedics
        13.4.3. Neurology
        13.4.4. Cardiology
        13.4.5. Others
    13.5. Market Value Forecast, by End-user, 2017–2031
        13.5.1. Veterinary Clinics
        13.5.2. Veterinary Hospitals
        13.5.3. Veterinary Institutes & Research Centers
    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Product Type
        13.7.2. By Animal Type
        13.7.3. By Application
        13.7.4. By End-user
        13.7.5. By Country/Sub-region
14. Latin America Veterinary Imaging Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product Type, 2017–2031
        14.2.1. Equipment
            14.2.1.1. Radiography (X-ray)
            14.2.1.2. Ultrasound Imaging
            14.2.1.3. Magnetic Resonance Imaging (MRI)
            14.2.1.4. Computed Tomography
            14.2.1.5. Endoscopy
            14.2.1.6. Others
        14.2.2. Imaging Reagents
        14.2.3. Imaging Software
    14.3. Market Value Forecast, by Animal Type, 2017–2031
        14.3.1. Small Animals
        14.3.2. Large Animals
    14.4. Market Value Forecast, by Application, 2017–2031
        14.4.1. Oncology
        14.4.2. Orthopedics
        14.4.3. Neurology
        14.4.4. Cardiology
        14.4.5. Others
    14.5. Market Value Forecast, by End-user, 2017–2031
        14.5.1. Veterinary Clinics
        14.5.2. Veterinary Hospitals
        14.5.3. Veterinary Institutes & Research Centers
    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Product Type
        14.7.2. By Animal Type
        14.7.3. By Application
        14.7.4. By End-user
        14.7.5. By Country/Sub-region
15. Middle East & Africa Veterinary Imaging Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Product Type, 2017–2031
        15.2.1. Equipment
            15.2.1.1. Radiography (X-ray)
            15.2.1.2. Ultrasound Imaging
            15.2.1.3. Magnetic Resonance Imaging (MRI)
            15.2.1.4. Computed Tomography
            15.2.1.5. Endoscopy
            15.2.1.6. Others
        15.2.2. Imaging Reagents
        15.2.3. Imaging Software
    15.3. Market Value Forecast, by Animal Type, 2017–2031
        15.3.1. Small Animals
        15.3.2. Large Animals
    15.4. Market Value Forecast, by Application, 2017–2031
        15.4.1. Oncology
        15.4.2. Orthopedics
        15.4.3. Neurology
        15.4.4. Cardiology
        15.4.5. Others
    15.5. Market Value Forecast, by End-user, 2017–2031
        15.5.1. Veterinary Clinics
        15.5.2. Veterinary Hospitals
        15.5.3. Veterinary Institutes & Research Centers
    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Product Type
        15.7.2. By Animal Type
        15.7.3. By Application
        15.7.4. By End-user
        15.7.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Player – Competition Matrix (By Tier and Size of companies)
    16.2. Market Share Analysis By Company (2022)
    16.3. Company Profiles
        16.3.1. 3M
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Johnson & Johnson
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. Medtronic Plc
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Siemens Healthineers AG
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. GE Healthcare
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Koninklijke Philips N.V.
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Samsung
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			